2 of 10 faith-based frameworks rate Coherus Oncology, Inc. (CHRS) compliant. Listed on Nasdaq. Industry: Biological Products, (No Diagnostic Substances). FaithScreener Consensus Score band: Non-Compliant. Score: 0/100.